Topline data expected in 1Q 2028 Phase 2 bipolar depression trial initiation follows positive Phase 2 results in acute ...

Prioritizing nonpharmacologic strategies, enhancing staff training, and distinguishing Delirium Superimposed on Dementia (DSD) are vital to improving outcomes for hospitalized patients with Alzheimer ...

Amantadine (Gocovri) is a treatment for Parkinson’s disease, but it can have side effects. These can range from nausea, dizziness, and insomnia to heart problems and suicidal thinking or actions.

The FDA approved a new monthly paliperidone palmitate (Erzofri) extended-release injectable suspension for treating schizophrenia in adults, Luye Pharma announced. An atypical antipsychotic, ...

A new Northwestern Medicine study has identified the molecular mechanisms that cause a commonly prescribed antipsychotic drug to produce harmful side effects similar to Parkinson’s disease symptoms, ...

The extended-release delivery coupled with the 351mg dose allows for single-dose initiation. Erzofri ® (paliperidone palmitate) extended-release injectable suspension is now available for the ...

Dubai: Antipsychotic medications are essential in managing psychiatric conditions like schizophrenia and bipolar disorder, but they often come with severe side effects. Among these, extrapyramidal ...

Erzofri is the first patented paliperidone palmitate long-acting injectable developed in China to receive FDA approval for treating schizophrenia and schizoaffective disorder, company says. The FDA ...

Tractography by diffusion tensor imaging has extended our knowledge on the contribution of damage to different pathways to residual motor function after stroke. Integrity of the corticospinal tract ...

The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...